Search

everythinglearnresearchcommunity

for

Search:↓

Herbal treatments can help manage PCOS symptoms.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

Some drugs can cause hair loss or growth, but hair usually returns to normal after stopping the drug.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Minoxidil helps lower severe blood pressure and promotes hair growth but can have serious side effects and must be used continuously.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Dermatological conditions are complex and treatments often have mixed results.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Oral medication is necessary to treat scalp fungus in children, with griseofulvin being the usual choice.

PCR-ELISA is better for identifying the fungus causing scalp infections in Ugandan children than traditional methods.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Early recognition and management of connective tissue diseases like lupus are crucial in young patients.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

To improve use of the contraceptive DMPA among adolescents, effectively manage side effects like menstrual changes and weight gain through counseling and guidance.

Targeting drugs to hair follicles can treat skin conditions, but reaching deep follicle areas is hard and needs more research.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.